<DOC>
	<DOCNO>NCT01725776</DOCNO>
	<brief_summary>The purpose study investigate concentration-effect relationship inhale milrinone prophylactic administration cardiac surgical patient preoperative pulmonary hypertension undergo cardiopulmonary bypass .</brief_summary>
	<brief_title>Inhaled Milrinone Cardiac Surgery</brief_title>
	<detailed_description>Milrinone elimination verify blood urine sample analysis .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>Patients schedule elective cardiac surgery CPB High risk patient : NYHA class IIIII Preoperative diagnostic pulmonary hypertension : Systolic pulmonary artery pressure ( sPAP ) &gt; 35 mm Hg ; Mean pulmonary artery pressure ( mPAP ) &gt; 25 mm Hg ; mAP/mPAP &lt; 3.0 ( induction anesthesia ) . Open Heart Surgery Contraindication transesophageal echocardiography ( TEE ) Hemodynamic instability surgery Emergency surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Pulmonary hypertension</keyword>
	<keyword>Cardiac surgery</keyword>
	<keyword>Cardiopulmonary Bypass ( CPB )</keyword>
</DOC>